Who invested in Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals's investors include InterWest Partners and Vivo Ventures.
United States · Funded startup
5 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Eiger BioPharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$25Mraised across 5 rounds since 2009, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $6.0M sold, first sale Nov 2015
No investor was named in the report.
From a historical funding recordSEC filing: $6.0M sold, first sale Nov 2015
From a historical funding recordSEC filing: $5.8M sold, first sale Apr 2011
Reported by sec.govSEC filing: $5.3M sold, first sale Apr 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Eiger BioPharmaceuticals's investors include InterWest Partners and Vivo Ventures.
Eiger BioPharmaceuticals has raised $25M across 5 rounds since 2009. One round did not disclose an amount, so the total is a floor.
Eiger BioPharmaceuticals's most recent round was a Debt of $6.0M in Nov 2015.
Eiger BioPharmaceuticals's largest round on record is $8.3M (Series A), in Feb 2009.
Eiger BioPharmaceuticals's first round on record, in Feb 2009, was backed by InterWest Partners and Vivo Ventures.
Eiger BioPharmaceuticals's latest named round is a Debt, in Nov 2015.
Eiger BioPharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.